Molecular diagnosis via NGS confirmed IDH1 R132H (in 11 tumors), IDH1 R132G (1 tumor), IDH1 R132L (1 tumor), and IDH2 R172G (1 tumor) mutations. This evidence concerns the gene IDH1 and neoplasm.